Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chondroitin sulfate - IBSA

Drug Profile

Chondroitin sulfate - IBSA

Alternative Names: Chondroitin 4-sulfate - IBSA; Chondroitin 4-sulfate sodium - IBSA; Chondroitin 6-sulfate - IBSA; Chondroitin 6-sulfate sodium - IBSA; Chondroitin sulfate A - IBSA; Chondroitin sulfate A sodium - IBSA; Chondroitin sulfate sodium - IBSA; Chondroitin sulphate - IBSA; Chondrosulf; Condrosulf (IBSA); Condrosulf (Salus Braumapharm)

Latest Information Update: 11 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator IBSA
  • Developer IBSA; Laboratoires Genevrier; Sanova Pharma; SPA
  • Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
  • Mechanism of Action Collagen stimulants; Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Osteoarthritis

Most Recent Events

  • 11 Jul 2019 No development reported - Phase-III for Osteoarthritis in Belgium (PO) (NDR batch #16)
  • 11 Jul 2019 No development reported - Phase-III for Osteoarthritis in Poland (PO) (NDR batch #16)
  • 13 Jun 2016 Efficacy data from the phase III CONCEPT trial released by IBSA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top